Low In Vitro Antifungal Activity of Tavaborole against Yeasts and Molds from Onychomycosis

The in vitro activity of tavaborole, an FDA-approved antifungal drug, was compared to that of four antifungal agents against 170 clinical fungal isolates originating from patients with onychomycosis. Tavaborole had low activity against all isolates compared to itraconazole, terbinafine, and fluconaz...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Abastabar, Mahdi, Haghani, Iman, Shokohi, Tahereh, Hedayati, Mohammad Taghi, Aghili, Seyed Reza, Jedi, Ali, Dadashi, Sulmaz, Shabanzadeh, Shafigheh, Hosseini, Tahereh, Aslani, Narges, Meis, Jacques F., Badali, Hamid
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2018
Témata:
Susceptibility
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6256807/
https://ncbi.nlm.nih.gov/pubmed/30224524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01632-18
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky